Benzinga's Top Upgrades, Downgrades For November 30, 2018

Top Upgrades

  • Goldman Sachs upgraded Myriad Genetics, Inc. MYGN from Sell to Neutral. Myriad Genetics shares rose 2.1 percent to $32.72 in pre-market trading.
  • Citi upgraded Sony Corp SNE from Neutral to Buy. Sony rose 2 percent to $52.91 in pre-market trading.
  • Citigroup upgraded Nantkwest Inc NK from Sell to Neutral. NantKwest shares fell 4.02 percent to close at $1.67 on Thursday.
  • Analysts at Goldman Sachs upgraded Abbott Laboratories ABT from Neutral to Buy. Abbott shares rose 1.2 percent to $74.10 in pre-market trading.
  • Barclays upgraded Fair Isaac Corporation FICO from Equal-Weight to Overweight. Fair Isaac shares rose 2.26 percent to close at $190.44 on Thursday.
  • Loop Capital upgraded Coupa Software Inc COUP from Hold to Buy. Coupa Software shares rose 3.7 percent to $65.00 in pre-market trading.
  • JP Morgan upgraded World Wrestling Entertainment, Inc. WWE from Neutral to Overweight. WWE shares rose 4.1 percent to $75.00 in pre-market trading.
  • First Analysis upgraded Palo Alto Networks Inc PANW from Outperform to Strong Buy. Palo Alto shares rose 0.5 percent to $177.00 in pre-market trading.
  • JP Morgan upgraded Cubic Corporation CUB from Neutral to Overweight. Cubic shares fell 3.23 percent to close at $59.03 on Thursday.
  • Wells Fargo upgraded Under Armour Inc UAA from Underperform to Market Perform. Under Armour shares rose 1.6 percent to $23.50 in pre-market trading.

 

Top Downgrades

  • Goldman Sachs downgraded Quest Diagnostics Inc DGX from Buy to Neutral. Quest shares rose 0.4 percent to $88.25 in pre-market trading.
  • Bank of America downgraded Goldman Sachs Group Inc GS from Buy to Neutral. Goldman Sachs shares fell 2 percent to $190.98 in pre-market trading.
  • JP Morgan downgraded Cree, Inc. CREE from Neutral to Underweight. Cree shares fell 0.28 percent to close at $45.96 on Thursday.
  • Mizuho downgraded Assertio Therapeutics Inc ASRT from Buy to Neutral. Assertio Therapeutics shares fell 1.33 percent to close at $5.21 on Thursday.
  • UBS downgraded Hannon Armstrong Sustnbl Infrstr Cap Inc HASI from Buy to Neutral. Hannon Armstrong shares fell 3.2 percent to $23.00 in pre-market trading.
  • Goldman Sachs downgraded Waters Corporation WAT from Neutral to Sell. Waters shares fell 1.3 percent to $200.83 in pre-market trading.
  • Citigroup downgraded Sodexo SA SDXAY from Buy to Neutral. Sodexo shares fell 1.14 percent to close at $20.76 on Thursday.
  • Bank of America downgraded Sprouts Farmers Market Inc SFM from Buy to Underperform. Sprouts Farmers shares fell 11.3 percent to $23.98 in pre-market trading.
  • Longbow Research downgraded American Woodmark Corporation AMWD from Buy to Neutral. American Woodmark shares fell 1.55 percent to close at $66.85 on Wednesday.
  • DNB Markets downgraded Frontline Ltd FRO from Buy to Hold. Frontline shares fell 10.1 percent to $7.30 in pre-market trading.

 

Top Initiations

  • Needham initiated coverage on Crispr Therapeutics AG CRSP with a Buy rating. The price target for Crispr Therapeutics is set to $62. Crispr Therapeutics shares closed at $38.72 on Thursday.
  • Analysts at Raymond James initiated coverage on Everi Holdings Inc EVRI with a Strong Buy rating. The price target for Everi is set to $11. Everi shares closed at $6.52 on Thursday.
  • H.C. Wainwright initiated coverage on Forty Seven Inc FTSV with a Buy rating. The price target for Forty Seven is set to $21. Forty Seven shares closed at $17.66 on Thursday.
  • Analysts at Needham initiated coverage on Casa Systems Inc CASA with a Buy rating. The price target for Casa Systems is set to $19. Casa Systems closed at $15.08 on Thursday.
  • Analysts at Jefferies initiated coverage on Eastgroup Properties Inc EGP with a Hold rating. The price target for Eastgroup Properties is set to $99. Eastgroup Properties shares closed at $100.23 on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!